An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
NETU-08-18 is a two-arm clinical study assessing efficacy and safety of a single oral dose of
netupitant and palonosetron, two antiemetic drugs, versus oral palonosetron, both given with
oral dexamethasone. The objective of the study is to demonstrate that netupitant and
palonosetron are more effective than palonosetron alone, to prevent nausea and vomiting
induced by moderately emetogenic cancer chemotherapy after administration of repeated cycles
of chemotherapy.